Life Extension Final Clerance Sale

Glaucoma References

Disease Prevention and Treatment, 5th edition

The references on this page correspond with the print version of Disease Prevention and Treatment, 5th edition. Since we continuously update the protocols online in response to new scientific developments, readers are encouraged to review the latest versions of the protocols.

  1. Steigerwalt, R.D., Belcaro, G., Morazzoni, P., Bombardelli, E., Burki, C., Schonlau, F. Mirtogenol potentiates latanoprost in lowering intraocular pressure and improves ocular blood flow in asymptomatic subjects. Clin Ophthalmol 14 (2010):471-6.
  2. Lascaratos G et al. Mitochondrial dysfunction in glaucoma: Understanding genetic influences. Mitochondrion. 2011 Nov 28. [Epub ahead of print]
  3. Lee S et al. drial dysfunction in glaucoma and emerging bioenergetic therapies. Exp Eye Res. 2011 Aug;93(2):204-12. Epub 2010 Aug 4.
  4. Gupta N et al. Glaucoma as a neurodegenerative disease. Curr Opin Ophthalmol. 2007 Mar;18(2):110-4.
  5. American Academy of Ophthalmology. www.geteyesmart.org/eyesmart/eye-health-news/press-releases/20110401.cfm, accessed 11-18-11.
  6. Newman-Casey, P.A., Talwar, N. Nan, B. Musch, D.C. Stein, J.D. The Relationship Between Components of Metabolic Syndrome and Open-Angle Glaucoma. Ophthalmology 118 (2011): 1318-26.
  7. Cross, J.M., Girkin, C.A., Owsley, C., McGwin, G. Jr. The association between thyroid problems and glaucoma. Br J Ophthalmol 92 (2008):1503-5.
  8. Gadia, R., Sihota, R., Dada, T., Gupta, V. Current profile of secondary glaucomas. Indian J Ophthalmol 56 (2008): 285-89.
  9. Yip, J.L., Broadway, D.C., Luben, R., Garway-Heath, D.F., et al. Physical Activity and Ocular Perfusion Pressure: The EPIC-Norfolk Eye Study. Invest Ophthalmol Vis Sci 52 (2011): 8186-92.
  10. Stone, E.M. Fingert, J.H., Alward, W.L.M., Nguyen, T.D., et al. Identification of a gene that causes primary open angle glaucoma. Science 275 (1997): 668-70.
  11. Kuchtey J, Olson LM, Rinkoski T, MacKay EO, Iverson TM, et al. Mapping of the Disease Locus and Identification of ADAMTS10 As a Candidate Gene in a Canine Model of Primary Open Angle Glaucoma. PLoS Genet 7(2011): e1001306.
  12. Patel, H. Y., Richards, A. J., De Karolyi, B., Best, S. J., Danesh-Meyer, H. V. and Vincent, A. L., Screening glaucoma genes in adult glaucoma suggests a multiallelic contribution of CYP1B1 to open-angle glaucoma phenotypes. Clinical & Experimental Ophthalmology 29 (2011): 4320-6.
  13. Bulboaca A et al. [Endothelial dysfunction in patients with open-angle glaucoma and atheromatous lesions]. logia. 2003;58(3):52-5.
  14. Resch H et al. helial dysfunction in glaucoma. Acta Ophthalmol. 2009 Feb;87(1):4-12. Epub 2008 May 27.
  15. Venkataraman ST et al. Vascular reactivity of optic nerve head and retinal blood vessels in glaucoma--a review. Microcirculation. 2010 Oct;17(7):568-81. doi: 10.1111/j.1549-8719.2010.00045.x.
  16. Mandal AK, Chakrabarti D. Update on congenital glaucoma. Indian J Ophthalmol 59 (2011) Suppl:S148-57.
  17. Weinreb, R.N., Kaufman, P.L. Glaucoma Research Community and FDA Look to the Future, II: NEI/FDA Glaucoma Clinical trial design and endpoints symposium: measures of structural change and visual function. Invest Ophthalmol Vis Sci 52 (2011): 7842-51.
  18. Kong, G.Y.X., et al. Hypothesis and Innovation: Mitochondrial Dysfunction and Glaucoma. J Glaucoma 18 (2009): 93-100.
  19. McElnea, E.M. et al. Oxidative stress, mitochondrial dysfunction and calcium overload in human lamina cribrosa cells from glaucoma donors. Mol Vis. 17 (2011): 1182-91.
  20. Fang, J.H., Wang, X.H,. Xu, Z.R., Jiang, .FG. Neuroprotective effects of bis(7)-tacrine against glutamate-induced retinal ganglion cells damage. BMC Neuroscience 11 (2010):31.
  21. Quinzii CM et al. Coenzyme Q and mitochondrial disease. Dev Disabil Res Rev. 2010 Jun;16(2):183-8.
  22. Rucker R et al. Potential physiological importance of pyrroloquinoline quinone. Altern Med Rev. 2009 Sep;14(3):268-77.
  23. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 9. Comparison of glaucoma outcomes in black and white patients within treatment groups. Am J Ophthalmol. 2001 Sep;132(3):311-20.
  24. Nguyen D, Flynn WJ. Response to Laser Trabeculoplasty in the Latino and Caucasian Population. ARVO 2011. Abstract 2611.
  25. Nishioka, K., Hidaka, T., Nakamura, S., et al. Pycnogenol, French maritime pine bark extract, augments endothelium-dependent vasodilation in humans. Hypertens Res. 30 (2007): 775-80.
  26. Alm A., Grierson I., Shields, M.B.. Side Effects Associated with Prostaglandin Analog Therapy. Surv Ophthalmol 53 (2008) Suppl1:S93-105.
  27. Zhou. L., Higginbotham, E., Yuc, B. Effects of ascorbic on levels of fibronectin, laminin and collagen type1 in bovine trabecular meshwork in organ culture. Current Eye Research 17 (1998): 211-17.
  28. Falsini, B., Marangoni, D., Salgarello, T., Stifano, G., et al. Effect of epigallocatechin-gallate on inner retinal function in ocular hypertension and glaucoma: a short-term study by pattern electroretinogram. Graefes Arch Clin Exp Ophthalmol 247 (2009): 1223-33
  29. Yuki K et al. Reduced-serum vitamin C and increased uric acid levels in normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 2010 Feb;248(2):243-8. Epub 2009 Sep 8.
  30. Zanon-Moreno V et al. Association between a SLC23A2 gene variation, plasma vitamin C levels, and risk of glaucoma in a Mediterranean population. Mol Vis. 2011;17:2997-3004. Epub 2011 Nov 17.
  31. Park,J.W., Kwon, H.J., Chung, W.S., Kim, C.Y., Seong, G.J. Short-Term Effects of Ginkgo Biloba Extract on Peripapillary Retinal Blood Flow in Normal Tension Glaucoma. Korean J Ophthalmol 25 (2011): 323-8.
  32. Park, K.H. Comparison of optic nerve head blood flow in normal-tension glaucoma with asymmetric visual field loss. J Korean Ophthalmol Soc 40 (1999):1318-23.
  33. Kim, S.W., Kim, C.Y., Seong, G.J. The short term effects of bimatoprost on optic nerve head and peripapillary retinal blood flow. J Korean Ophthalmol Soc. 45 (2004): 1322-1329.
  34. Khatun, S., Chatterjee, N.C., Cakilcioglu, U. Antioxidant activity of the medicinal plant Coleus forskohlii Briq. African Journal of Biotechnology 10 (2011):2530-35.
  35. Caprioli, J., Sears, M., Bausher, L., et al. Forskolin lowers intraocular pressure by reducing aqueous inflow. Invest Ophthalmol Vis Sci 25 (1984):268-77.
  36. Hartman, H.B., Roehr, J.E., Kotyuk, B.L., et al. HP 663: a novel compound for the treatment of glaucoma. Drug Dev Res. 12 (1988):197-209.
  37. Gaspar, A.Z., Gasser, P., Flammer, J. The influence of magnesium on visual field and peripheral vasospasm in glaucoma. Ophthalmologica 209 (1995):11-13.
  38. Altura, B.M., Altura, B.T. Magnesium and the cardiovascular system: experimental and clinical aspects updated. In Sigel H, Sigel A (eds): “Metal Ions in Biological Systems, Vol. 26, Compendium on Magnesium and Its Role in Biology, Nutrition, and Physiology.” New York: Marcel Dekker, pp359-416, 1990 .
  39. Head, K. Natural Therapies for Ocular Disorders Part Two: Cataracts and Glaucoma. Alternative Medicine Review 6 (2001): 141-66.
  40. Bruhn, R.L., Stamer, W.D., Herrygers, L.A., Levine, J.A., Noecker, R.J. Relationship Between Glaucoma and Selenium Levels in Plasma and Aqueous Humour. Br J Ophthalmol 93 (2009): 1155-58.
  41. National Eye Institute. http://www.nei.nih.gov/amd/summary.asp. Accessed December 10, 2011.
  42. Belforte, N.A., Moreno, M.C., de Zavalía, N., Sande, P.H., et al. Melatonin: A Novel Neuroprotectant for the Treatment of Glaucoma. J Pineal Res 48 (2010): 353-64.
  43. Pescosolido N et al. Oral administration of an association of forskolin, rutin and vitamins B1 and B2 potentiates the hypotonising effects of pharmacological treatments in POAG patients. Clin Ter. 2010;161(3):e81-5.
  44. Merritt, J,C,, Crawford, W.J., Alexander, P.C., et al. Effect of marijuana on intraocular and blood pressure in glaucoma. Ophthalmology 87 (1980):222-8.
  45. Peczon, J.D., Grant, W.M. Sedatives, stimulants, and intraocular pressure in glaucoma. Arch Ophthalmol. 72 (1964): 178-88.
  46. Kang, J.H., Willett, W.C., Rosner, B.A., Hankinson, S.E., Pasquale, L.R. Caffeine Consumption and the Risk of Primary Open-Angle Glaucoma: A Prospective Cohort Study. Invest Ophthalmol Vis Sci. 49 (2008): 1924-1931.
  47. Wen, X., Takenaka, M., Murata, M., Homma, S. Antioxidative activity of a zinc-chelating substance in coffee. Biosci Biotechnol Biochem 68 (2004): 2313-8.
  48. Clifford, M.N. Chlorogenic acids: Their complex nature and routine determination in coffee beans. Food Chem 4 (1979): 63-71.
  49. Stich, H.F. The beneficial and hazardous effects of simple phenolic compounds. Mutat Res 259 (1991): 307-24.
  50. Nakajima, Y. Shimazawa, M., Mishima, S., Hara, H. Water extract of propolis and its main constituents, caffeoylquinic acid derivatives, exert neuroprotective effects via antioxidant actions. Life Sciences 80 (2007): 370-7.
  51. Zhang, X., Kahende, J., Fan, A.Z., Barker, L., et al. Smoking and visual impairment among older adults with age-related eye diseases. Prev Chronic Dis 8 (2011): A1-8.
  52. Klein, B.E., Klein, R., Ritter, L.L. Relationship of drinking alcohol and smoking to prevalence of open-angle glaucoma. The Beaver Dam Eye Study. Ophthalmology. 100 (1993): 1609-1613.
  53. Edwards, R., Thornton, J., Ajit, R., Harrison, R.A., Kelly, S.P. Cigarette smoking and primary open angle glaucoma: a systematic review. J Glaucoma. 17 (2008): 558-566.